Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
    • Video Resources
    • SSF Ambassador Program
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.



    Healthcare, Education

    Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study

    January 26, 2026 ayushis Comments Off on Monophasic Synovial Sarcoma of the Posterior Pharyngeal Wall: A Rare Case Study
    Three people in medical attire are standing and talking in a brightly lit hallway. The image is blurred, and there is an exclamation mark inside a triangle warning icon overlayed in the center.
    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care.

    Synovial sarcoma most often develops in the extremities, but in rare cases, it can arise in the head and neck region. A published case study in the European Archives of Oto-Rhino-Laryngology highlights one such rare presentation: monophasic synovial sarcoma originating in the posterior pharyngeal wall.

    Although uncommon, head and neck synovial sarcoma presents unique diagnostic and treatment challenges due to the complexity of surrounding anatomy and the critical functions involved in breathing, swallowing, and speech. Studies like this one provide valuable insight for clinicians and patients navigating these rare diagnoses.

    A rare and challenging diagnosis

    In this case, a 25-year-old patient presented with symptoms including difficulty breathing while lying down, snoring, and trouble swallowing solid foods. Initial imaging and biopsy suggested a benign tumor, a situation that is not uncommon with synovial sarcoma due to its tendency to appear well-defined and non-aggressive on early scans.

    As symptoms progressed, further imaging and pathology revealed the diagnosis of monophasic synovial sarcoma of the posterior pharyngeal wall. This highlights a known challenge with synovial sarcoma: it can closely mimic benign conditions, leading to delays in diagnosis, particularly in rare anatomical locations like the head and neck.

    Imaging and pathology findings

    Advanced imaging showed a heterogeneous mass with areas of calcification—an imaging feature seen in a subset of synovial sarcoma cases. Definitive diagnosis was confirmed through histopathology, immunohistochemistry, and cytogenetic testing, which identified the characteristic t(X;18) chromosomal translocation associated with synovial sarcoma.

    The tumor was classified as monophasic, meaning it consisted primarily of spindle-shaped cells, a subtype that is frequently misdiagnosed due to its resemblance to other soft tissue tumors.

    Surgical treatment and reconstruction

    The primary treatment approach was wide surgical excision aimed at achieving clear margins. Due to the tumor’s size and location, the surgery required complex access and reconstruction. The surgical team used a lateral trapezius flap—a less commonly used reconstructive technique—to repair the defect created after tumor removal.

    This reconstructive approach allowed restoration of the pharyngeal wall while preserving critical structures involved in swallowing and airway protection. The study highlights this technique as a potential option for large defects in similar cases.

    Role of additional therapies

    Following surgery, the patient received radiation therapy. Chemotherapy was initiated but discontinued after one cycle due to side effects. At follow-up, the patient showed no evidence of disease and was able to resume oral intake with supportive therapy.

    While the role of chemotherapy in head and neck synovial sarcoma remains debated, studies suggest that a multidisciplinary approach—including surgery, radiation, and careful long-term surveillance—offers the best chance for disease control.

    Why this study matters

    Although this case represents a single patient, it adds to a limited body of knowledge about synovial sarcoma in the head and neck region. For patients and families affected by synovial sarcoma outside of the extremities, studies like this help improve understanding of how the disease can present, how it is diagnosed, and what treatment options may look like.

    Importantly, it also reinforces the value of second opinions, specialized pathology review, and care at centers experienced with sarcoma—especially when symptoms persist despite reassurance that a mass may be benign.

    Looking ahead

    Head and neck synovial sarcoma remains rare, but continued documentation and study are essential to improving diagnosis, treatment strategies, and long-term outcomes. Research like this contributes to ongoing efforts to refine surgical techniques, explore reconstruction options, and better understand the biology of this complex disease.

    For patients navigating synovial sarcoma of the head and neck, awareness and advocacy remain critical tools—both for timely diagnosis and access to specialized care.

    Content Warning:
    This article references a published medical case study that includes graphic surgical images involving the head and neck region. While the information may be valuable and informative, some readers may find the images difficult to view. Please proceed with care. Original study here.

    For more detailed information about Synovial Sarcoma resources and support, please visit our website.

    • Monophasic Synovial Sarcoma
    • Synovial Sarcoma Foundation
    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (4)
    • Children (1)
    • CHOP (3)
    • Clinical Trial (3)
    • Development (11)
    • Dr. Theodore Laetsch (3)
    • Education (26)
    • Europe Expansion (1)
    • Healthcare (13)
    • Latest News (22)
    • Patient Story (1)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (21)
    • SSF Ambassador Program (1)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (7)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
      Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma
    • Webinar recording poster titled “Inside the Synovial Sarcoma Foundation” featuring speakers Nathan Imperiale and Philip Leider, recorded October 9, 2026, and sponsored by US WorldMeds.
      Two Leaders, One Mission: Nathan Imperiale and Philip Leider on Synovial Sarcoma
    • Transparent blue spheres with molecular structures inside float near visible DNA double helix strands, creating a scientific and futuristic background focused on genetics and biotechnology.
      Synovial Sarcoma of the Hyoid Bone: A Rare Case

    Tags

    #AYACancer #CancerResearch #ClinicalTrials #Immunotherapy #KnowYourOptions #MAGEA4 #NYESO1 #PatientAdvocacy #RareCancer #RareDisease #Sarcoma #SarcomaAwareness #SarcomaCommunity #SoftTissueSarcoma #SynovialSarcoma #SynovialSarcomaFoundation Afami-cel Afamitresgene autoleucel Cancer Research CHOP immunotherapy MAGE-A4 synovial sarcoma NY-ESO-1 synovial sarcoma Rare Cancer rare cancer research rare soft tissue sarcoma research sarcoma research sarcoma treatment soft tissue sarcoma solitary fibrous tumor Synovial Sarcoma synovial sarcoma biomarker testing synovial sarcoma case report synovial sarcoma diagnosis Synovial Sarcoma Foundation synovial sarcoma misdiagnosis synovial sarcoma registry synovial sarcoma research synovial sarcoma treatment T-Cell Therapy targeted therapy TECELRA Tecelra synovial sarcoma webinar

    Related posts

    Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
    Latest News, Synovial Sarcoma Registry

    Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    October 28, 2026 ayushis Comments Off on Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    A new study in Advanced Science (October 12, 2026) shows what becomes possible when patients donate tumor tissue and researchers pair it with detailed clinical and genetic data. The same idea drives the Synovial Sarcoma Registry and Biorepository, and every patient who joins makes the next study possible. What the study found Over ten years, […]

    Close-up of blue gloved hands adjusting a microscope with two visible objective lenses, focusing on a glass slide in a laboratory setting.
    Education, Research

    The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    September 14, 2026 ayushis Comments Off on The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    A new study published in PLOS One by Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim from Seoul National University and Ewha Womans University, South Korea, examines a type of cell found in the tissue surrounding tumors, called cancer-associated fibroblasts (CAFs), and asks whether they can predict how a sarcoma patient will respond to immunotherapy. What […]

    A collage showing a woman in various moments: in a headscarf, in military attire, hugging her children, on her wedding day, and smiling with her family. Text reads, “Kaela’s Story.”.
    Patient Story, Synovial Sarcoma Registry

    In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life

    August 11, 2026 ayushis Comments Off on In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life

    Kaela Graham-Bowman’s story reached national audiences this year when she was featured on 60 Minutes Australia. An Afghanistan veteran and nurse, Kaela was diagnosed with synovial sarcoma in 2020 at age 28, while working as an oncology nurse herself. What followed was a six-year fight through surgery, chemotherapy, a devastating relapse, and eventually a groundbreaking […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch